» Articles » PMID: 27075111

Extracellular MicroRNA-21 and MicroRNA-26a Increase in Body Fluids from Rats with Antigen Induced Pulmonary Inflammation and Children with Recurrent Wheezing

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2016 Apr 15
PMID 27075111
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aims to find out whether extracellular miRNAs is implicated in recurrent childhood wheezing with asthmatic risk.

Methods: One hundred and forty children of Chinese Han population were recruited for this study. Plasma and intracellular miRNAs from children with recurrent wheezing and rats with antigen induced pulmonary inflammation (AIPI) were detected by using reverse transcription-quantitative PCR. Differential leukocytes in blood were automatically counted. Total IgE was detected by enzyme-linked immunosorbent assay. Clinical implication in diagnosis was evaluated using receiver operating characteristic curves.

Results: The increase of plasma miR-21 and miR-26a was screened out from 11 candidate miRNAs and validated in wheezing children. The level of expression for both miRNAs were comparable in different age and gender. Plasma miR-21 was more preferable to miR-26a and total IgE for diagnosis. Plasma miR-21 and miR-26a levels were not significantly correlated with various leukocyte counts or miRNA expression in blood cells. In acute and chronic AIPI rats, miR-21 levels increased in both plasma and lavaged lung compared with control. Moreover, circulating miR-21 and miR-26a levels were highly positively correlated with infiltrated cell counts in bronchoalveolar lavage fluid of AIPI rats.

Conclusions: Circulating miR-21 and miR-26a increase in wheezing children and AIPI rats. This not only manifests their strong clinical implication in recurrent childhood wheezing with asthma risk, but also provides novel insights into the role of extracellular miRNAs during development of airway inflammation and recurrent wheezing.

Citing Articles

Alleviation of chemotherapy-induced acute lung injury via NLRP3/ ASC/ Caspase-1 signaling pathway.

Sherif I, Al-Shaalan N Toxicol Res (Camb). 2022; 11(3):417-425.

PMID: 35782645 PMC: 9244212. DOI: 10.1093/toxres/tfac021.


MicroRNAs-A Promising Tool for Asthma Diagnosis and Severity Assessment: A Systematic Review.

Kyyaly M, Vorobeva E, Kothalawala D, Fong W, He P, Sones C J Pers Med. 2022; 12(4).

PMID: 35455659 PMC: 9030707. DOI: 10.3390/jpm12040543.


MiRNA-21 Regulates Bronchial Epithelial Cell Proliferation by Activating Tgfβ1/Smad Signaling Pathway and Its Correlation with Asthma Severity in Children.

Kang Y, Bai M, Deng L, Fan L, Wang X Iran J Public Health. 2022; 50(10):1973-1982.

PMID: 35223564 PMC: 8819233. DOI: 10.18502/ijph.v50i10.7497.


PCV2 Regulates Cellular Inflammatory Responses through Dysregulating Cellular miRNA-mRNA Networks.

Li C, Sun Y, Li J, Jiang C, Zeng W, Zhang H Viruses. 2019; 11(11).

PMID: 31766254 PMC: 6893612. DOI: 10.3390/v11111055.


Pleiotropic microRNA-21 in pulmonary remodeling: novel insights for molecular mechanism and present advancements.

Jiang C, Guo Y, Yu H, Lu S, Meng L Allergy Asthma Clin Immunol. 2019; 15:33.

PMID: 31139230 PMC: 6528201. DOI: 10.1186/s13223-019-0345-2.


References
1.
Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N . Serum microRNAs are promising novel biomarkers. PLoS One. 2008; 3(9):e3148. PMC: 2519789. DOI: 10.1371/journal.pone.0003148. View

2.
Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, Fitzgerald J . Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-78. DOI: 10.1183/09031936.00138707. View

3.
Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, Raj J . MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol. 2010; 299(6):L861-71. PMC: 3006273. DOI: 10.1152/ajplung.00201.2010. View

4.
Collison A, Mattes J, Plank M, Foster P . Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011; 128(1):160-167.e4. DOI: 10.1016/j.jaci.2011.04.005. View

5.
Esposito S, Ierardi V, Daleno C, Scala A, Terranova L, Tagliabue C . Genetic polymorphisms and risk of recurrent wheezing in pediatric age. BMC Pulm Med. 2014; 14:162. PMC: 4210469. DOI: 10.1186/1471-2466-14-162. View